RESUMEN
INTRODUCTION: Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases worldwide. Some researchers have suggested that the serum vitamin D (Vit D) level may relate to disease activity. The current study was designed to identify the correlation between vitamin D prescription and prevention of relapses in rheumatoid arthritis. PATIENTS AND METHOD: A double blinded, randomized controlled trial study was performed using 80 RA patients. RA was controlled and patients were in remission during the past 2 months. Serum level of Vit D in the studied patients was below 30 ng/dl. Patients were randomly allocated to receive Vit D or placebo. In the 6-month follow-up period, the Disease Activity Score 28 (DAS28) was used in case of relapses as an index of RA activity to compare the two groups. RESULTS: The flare rate was not different between two groups (p > 0.05). The odds ratio of the rate of decline in patients of the trial group compared with the control group was 1.17 (not significant; p > 0.05). The mean DAS28 between the two patient groups was not significant (p > 0.05). CONCLUSION: A low Vit D level was not identified to be a risk factor for RA severity or flare ups; however, although not statistically significant, Vit D treatment might be clinically effective. Further studies are needed with more emphasis on the issue of cost effectiveness and clinical importance to provide more information.
Asunto(s)
Artritis Reumatoide/sangre , Artritis Reumatoide/tratamiento farmacológico , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/prevención & control , Vitamina D/sangre , Vitamina D/uso terapéutico , Artritis Reumatoide/diagnóstico , Biomarcadores/sangre , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Resultado del Tratamiento , Deficiencia de Vitamina D/diagnósticoRESUMEN
The purpose of this study was to investigate the relationship between fasting serum leptin, adiponectin and resistin levels and bone mineral density (BMD) in osteoporosis patients and a non-osteoporosis control group. We studied 81 non-diabetic osteoporosis patients (92 % female, 8 % male; mean age 54.5 ± 15.5 years and body mass index [BMI] 28.2 ± 4.6) and 120 non-diabetic individuals with normal BMD as controls (86 % female, 14 % male; mean age 39.7 ± 10.4 years and BMI 28.8 ± 4.4). BMD was studied by dual-energy X-ray absorptiometry from the lumbar spine (L1-L4) and femoral neck and fasting blood samples were taken for biochemical measurement of fasting blood glucose, leptin, adiponectin and resistin. Fasting levels of plasma adiponectin had a significant negative correlation with BMD of the femoral neck and lumbar spine in the osteoporosis group (r = -0.478, P = 0.003, r = -0.513, P = 0.023) but not in the non-osteoporosis group (r = -0.158, P = 0.057, r = -0.23, P = 0.465). Fasting plasma levels of resistin were significantly correlated only with femur BMD in the osteoporosis group, and not significantly correlated with lumbar spine BMD (r = -0.244, P = 0.048 vs r = 0.276, P = 0.56). Leptin did not have a significant correlation with BMD in either the osteoporosis or non-osteoporosis groups (P > 0.05). Adiponectin had a significant negative correlation with BMD of the lumbar spine and femoral neck. The correlation between leptin and resistin are not inconclusive.
Asunto(s)
Adiponectina/sangre , Densidad Ósea/fisiología , Leptina/sangre , Osteoporosis/sangre , Resistina/sangre , Adulto , Ayuno , Femenino , Cuello Femoral/diagnóstico por imagen , Humanos , Vértebras Lumbares/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Osteoporosis/diagnóstico por imagen , RadiografíaRESUMEN
INTRODUCTION: Frozen shoulder or adhesive capsulitis is a relatively common encountered musculo-skeletal disease in which arouses following soft tissue involvement of glenohumeral joint and presents with pain and limitation of shoulder' active and passive motions. The incidence of frozen shoulder among diabetic patients is about 10-20%, stiffness in such patients is more severe and should be managed actively. Local Glucocorticoid injection, NSAIDs and physiotherapy each can relief the symptoms. The aim of this study was to compare the efficacy of glenohumeral injection of Glucocorticoid with NSAIDs in frozen shoulder of diabetic patients. METHOD: The randomized clinical trial study conducted during Feb 2009-Aug 2010 on diabetic patients with frozen shoulder that were referred to rheumatology and endocrinology clinics, Yazd, Iran. Diagnostic criteria of capsulitis were pain of shoulder and range of motion limitation in all directions. The patients were divided into 2 groups, patients of first group received NSAID while the latter group were undergone intra-articular corticosteroid injection. After 1 week, home exercise was done for both group and evaluation of the patients after first visit was done likewise 2nd, 6th, 12th and 24th weeks. All registered data were transformed into SPSS-15 software and analyzed. RESULTS: Totally 57 patients (19 males (33.3%) and 38 females (66.7%) were included in the analysis. There was no significant difference between sex (P=0.4) and age (P=0.19) of patients. No significant relation was detected between 2 groups after 24 weeks according to range of motion in flexion (P=0.51), abduction (P=0.76), external rotation (0.12) and internal rotation (P=0.91). Also any significant difference in pain score was not detected (P=0.91). CONCLUSION: Based on our study, both intra-articular corticosteroid and NSAID are effective in treatment of adhesive capsulitis and there is no significant difference between efficacies of these 2 treatment modalities in diabetic patients.
Asunto(s)
Corticoesteroides/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Bursitis/tratamiento farmacológico , Complicaciones de la Diabetes/tratamiento farmacológico , Naproxeno/uso terapéutico , Articulación del Hombro/efectos de los fármacos , Triamcinolona/uso terapéutico , Corticoesteroides/administración & dosificación , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Bursitis/diagnóstico por imagen , Bursitis/inmunología , Bursitis/terapia , Terapia Combinada , Complicaciones de la Diabetes/inmunología , Terapia por Ejercicio , Femenino , Humanos , Inyecciones Intraarticulares , Irán , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Pacientes Desistentes del Tratamiento , Radiografía , Rango del Movimiento Articular/efectos de los fármacos , Articulación del Hombro/diagnóstico por imagen , Articulación del Hombro/inmunología , Equivalencia Terapéutica , Triamcinolona/administración & dosificación , UltrasonografíaRESUMEN
Behcet's disease (BD) is the only systemic vasculitis involving both arteries and vein in any sizes. It frequently encounters in rheumatology clinics. It has some major morbidities and even fatal outcomes in some cases. The aim of this paper is to analyze the main concepts on pathophysiology and treatment options in BD, focusing on cardiovascular aspects, thrombosis, and potential future treatment.
RESUMEN
INTRODUCTION: Cryoglobulins are found in a wide spectrum of disorders but are often transient and without clinical implications. The so-called essential mixed cryoglobulinaemia shows a striking association with hepatitis C virus (HCV) infection (greater than 90 percent). Type II cryoglobulinaemia is the major extrahepatic manifestation of HCV infection. This study aims to investigate the frequency of cryoglobulinaemia in HCV-positive patients in central Iran. METHODS: 50 HCV-positive patients referred to the Shaheed Sadoughi Hospital in Yazd, Iran from May 2004 to December 2005, were included in the study. Their sera were assessed for cryoglobulins. The sera were separated by centrifugation at 37 degrees Celsius and placed in a four degrees Celsius refrigerator in two tubes, one simple and the other, a Wintrobe tube, to see if precipitation occurs during a 48-hour up to a seven-day period. RESULTS: In this study, 50 HCV positive patients were evaluated. Only two patients were female. Mean age was 32 years (ranging from 17 to 52 years). In eight patients, the cryoglobulin test was positive. In seven patients, the test became positive less than 72 hours after sampling. Only one patient who was positive for cryoglobulinaemia, had clinical manifestation of frank vasculitis. CONCLUSION: The prevalence of cryoglobulinaemia in Iran may be lower than other areas, and it may be due to a higher prevalence of cryoglobulinaemia in females and lower prevalence of cryoglobulinaemia in HCV genotype-1a. Most of the cases in our study were male and the more prevalent genotype in Iran is genotype-1a.
Asunto(s)
Crioglobulinemia/diagnóstico , Crioglobulinemia/epidemiología , Hepacivirus/aislamiento & purificación , Hepatitis C/diagnóstico , Hepatitis C/epidemiología , Adolescente , Adulto , Distribución por Edad , Estudios de Cohortes , Comorbilidad , Femenino , Humanos , Irán/epidemiología , Pruebas de Función Hepática , Masculino , Persona de Mediana Edad , Prevalencia , Probabilidad , Índice de Severidad de la Enfermedad , Distribución por SexoRESUMEN
INTRODUCTION: Low back pain and lumbar radicular pain are the leading causes of job loss worldwide. Therapeutic approaches to lumbar radicular pain, including sciatica and spinal canal stenosis, are diverse. Many clinicians use 80 mg long-acting glucocorticoids in epidural steroid injections (ESI). The aim of this study is to compare the clinical response of 80 mg versus 40 mg methylprednisolone in ESI. METHODS: 84 patients with newly exacerbated lumbar radicular pain were randomly al located into two groups. 43 patients under went ESI with 80 mg Depo-Medrol and 41 age- and sex-matched cases received 40 mg Depo-Medrol as the comparison group. The pain in the second week, and every month thereafter was assessed using a visual analogue scale (VAS). RESULTS: Remarkable improvement in one month VAS occurred in 64 cases (75 percent) from both groups. VAS values between 80 mg and 40 mg groups were comparable in the two-week (p-value is 0.827) and three-month (p-value is greater than 0.746) post-injection periods. Slightly better results were shown in patients in the 40 mg group after one month. CONCLUSION: In the case of lumbar radicular pain, ESI with low dose (40 mg) methylprednisolone is as effective as high dose (80 mg) with comparable results and less adverse profile.
Asunto(s)
Antiinflamatorios/administración & dosificación , Glucocorticoides/administración & dosificación , Metilprednisolona/análogos & derivados , Radiculopatía/tratamiento farmacológico , Adulto , Femenino , Humanos , Inyecciones Epidurales , Masculino , Metilprednisolona/administración & dosificación , Acetato de Metilprednisolona , Dimensión del DolorRESUMEN
The anterior, medial, and posterior heights and the A/P and M/P ratios of the spine (T5-L4) in 41 normal premenopausal Iranian women were determined using an imaging densitometer (Expert XL) and dual energy X-ray absorptiometry (DXA) method. All the women were healthy (age 20-39 years, and height 149-171 cm), without any signs of vertebral fractures, and with normal bone mineral density (BMD) of the spine and femoral neck (T-score>-1.5). The vertebral heights were normalized using the Expert XL software, and the average vertebral height for the L2-L4 vertebrae was taken to minimize the effect of variation of body size among the subjects. The Z-score for all vertebral heights (T5-L4) averaged -0.68, with the A/P and M/P ratios coming to +0.34 and +0.49, respectively. It showed the normalization procedure not to correct the differences of vertebral heights in Iranian women. The average of the three heights (H (avg)) correlated fairly well with the stature of the subject (r=0.47, p<0.05), but no correlation was found between H (avg) and subject age (p>0.05). The lower vertebral heights in older women in comparison with the younger women (0.4 mm) obtained in our study can be attributed to the relatively shorter stature of older women (mean 154 vs 159 cm for younger women, p<0.05). It was concluded that the normalization procedure used in the software does not equally apply to Iranian women due to their having different heights than those of American and northern European women, from whom the reference data for the Expert XL software have been gathered. The reference values thus obtained are therefore not accurate for our population group and a separate study with a bigger and more varied sample group is needed for obtaining more definitive results.